Bioventus Inc. (BVS)
Nasdaq: BVS · Surgical & Medical Instruments & Apparatus · Durham, NC · filing with the SEC since 2016
Grade5.2
◀ Past 5.0● Present 5.9▶ Future 4.4
Who owns Bioventus Inc.
As filed with the SECHolders of 5% or more
1
Nantahala Capital Management, LLC holds 9.03% of Class A Common Stock, $0.001 par value per share, as its SCHEDULE 13G/A filed Feb 13, 2026 says.
Directors and officers
15
report now, of 22 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Nantahala Capital Management, LLC
SCHEDULE 13G/A · filed Feb 13, 2026 · Class A Common Stock, $0.001 par value per share · 7.96% in Aug 14, 2025
Blackrock, Inc.
SCHEDULE 13G/A · filed Oct 27, 2026 · Class A Stock · reported falling below 5%, from 5.02% in Jul 27, 2026
What BVS reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Bioness, Inc
A company bought · acquisition · owns, named in the 10-K filed Mar 5, 2026
13 subsidiaries in 5 countries, from the list filed with the 10-K filed Mar 5, 2026.
Insider tradesForm 4
3sales
0purchases
0sales on a scheduled plan
2people selling
$300,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 42 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Mcmurry-Heath Michelle | director | 2 | $200,000 | 0 | 0 | $0 |
| Nohra Guy P | director | 1 | $100,000 | 0 | 0 | $0 |